Impact of Stress on Management of BAVU Ventilation (Self-filling Bag With One-way Valve) by Healthcare Professionals.
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Jun 25, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how stress affects healthcare professionals when they perform manual ventilation using a special bag and valve system. The main goal is to understand if a stressful event changes the way they deliver air to patients, focusing on important factors like pressure, frequency, and volume of ventilation. To do this, volunteers will participate in a simulation where they will practice ventilating a manikin, and researchers will record the data from these sessions.
Eligible participants include any healthcare professional who may need to perform manual ventilation, regardless of age or gender. However, those who do not have access to the necessary simulation equipment or choose not to participate will be excluded. Participants can expect to engage in a safe and controlled environment, helping to gather valuable information that could improve patient care during stressful situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any healthcare professional who may be required to perform manual ventilation
- Exclusion Criteria:
- • Unavailability of simulation equipment
- • Refusal to participate
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Patients applied
Trial Officials
Thomas Godet
Principal Investigator
University Hospital, Clermont-Ferrand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported